The FDA granted fast track designation to SAR446597, an intravitreal gene therapy for the treatment of geographic atrophy due to age-related macular degeneration, according to a press release from ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

Autosomal dominant optic atrophy (ADOA) causes progressive childhood blindness — but what if we could stop it? Boston Children's Hospital researchers Drs. Thomas Schwarz and Chen Ding have identified ...